Cynosure has announced the U.S. Food and Drug Administration (FDA) clearance of the Potenza radiofrequency (RF) microneedling device, the first and only FDA-cleared four-mode RF microneedling device, which offers clinicians versatility and personalized treatments for patients.
The Potenza device's four modes (monopolar or bipolar, delivered at either 1 MHz or 2 MHz frequency) offer numerous customized microneedling treatments for patients and allow practitioners to deliver both shallow and deep treatments on a single system. The device's monopolar RF mode delivers energy across a large area of tissue for deep heating and skin tightening through soft tissue coagulation—not only on the face, but anywhere on the body. The bipolar RF mode offers more concentrated delivery of energy to treat superficial tissue and provide ideal skin revitalization results. It also is equipped with Tiger Tip technology, the first semi-insulated needles of its design, which allow practitioners to expand the treatment zone and address more tissue per treatment, which translates to quicker sessions for patients without sacrificing the epidermis. The device also is armed with a single-needle handpiece designed to target and improve blemishes.

Read more at PR Newswire >>